In 1986, the diagnosis of the Marfan syndrome was codified on the basis of clinical criteria in the Berlin nosology [Beighton et al., 19881. Over time, weaknesses have emerged in these criteria, a problem accentuated by the advent of molecular testing. In this paper, we propose a revision of diagnos
β¦ LIBER β¦
Rethinking the diagnostic criteria for thrombocytopenic purpura
β Scribed by Dr. Carter R. Bishop
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 72 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Revised diagnostic criteria for the Marf
β
De Paepe, Anne; Devereux, Richard B.; Dietz, Harry C.; Hennekam, Raoul C. M.; Py
π
Article
π
1996
π
John Wiley and Sons
π
English
β 25 KB
π 2 views
Diagnostic criteria for multiple scleros
β
Chris H. Polman; Stephen C. Reingold; Brenda Banwell; Michel Clanet; Jeffrey A.
π
Article
π
2011
π
John Wiley and Sons
π
English
β 140 KB
π 2 views
Diagnostic criteria for multiple scleros
β
Chris H. Polman; Stephen C. Reingold; Gilles Edan; Massimo Filippi; Hans-Peter H
π
Article
π
2005
π
John Wiley and Sons
π
English
β 79 KB
π 1 views
Splenectomy for immune thrombocytopenic
β
James P. Dolan; Brett C. Sheppard; Thomas G. DeLoughery
π
Article
π
2008
π
John Wiley and Sons
π
English
β 171 KB
π 2 views
Rituximab for the treatment of refractor
β
Lydia Koulova; Doru Alexandrescu; Janice P. Dutcher; Kevin P. O'Boyle; Saji Eape
π
Article
π
2004
π
John Wiley and Sons
π
English
β 162 KB
π 2 views
Three patients (one with idiopathic thrombocytopenic purpura [ITP] and two with thrombotic thrombocytopenic purpura [TTP]) were treated with rituximab (anti-CD20 chimeric antibody) at a dose of 325 mg/m 2 administered weekly after they failed standard therapies. The patient with ITP who did not resp
Reexamination of the need for treatment
β
Michael Auerbach; Harold Ballard
π
Article
π
2006
π
John Wiley and Sons
π
English
β 338 KB
π 2 views